High-throughput blood diagnostics from a single finger-prick (producing hundreds of different assay results from one small blood sample) will not be technologically feasible for many decades and likely not within the current generation's lifetime without some significant unforeseen breakthrough.
“we're talking about 19 years ago, and we're saying here it's not going to be possible to do hundreds of these things maybe in our lifetime. We're talking about decades from there needs to be some significant breakthrough.”
View on YouTube
Explanation
High-throughput single-finger-prick blood diagnostics did not take decades; by the mid-2020s numerous at-home and point-of-care multi-analyte blood testing services (Function Health, various lab-on-chip devices) had emerged, far sooner than the "decades" timeframe predicted, though a Theranos-style hundreds-from-one-drop device remains unrealized.
Calendar year 2022 will be characterized by a major correction in high-growth and tech-related asset prices (a sustained downward repricing versus 2020–2021 levels).
“I predicted and you guys had similar predictions on just a few weeks ago that this would be the 2022, would be the year of the correction.”
View on YouTube
Explanation
2022 was indeed a major correction year for tech and growth stocks; the Nasdaq fell about 33% and many high-growth names fell 60-80% from 2021 highs.
If the volatility of the 10-year Treasury yield continues to slow as it was in early Q1 2022, then a roughly 100 basis point increase in interest rates will flush most inflation through the system, leading to a brief market pullback in Q1 2022 followed by a rapid rebound in risk assets as sidelined capital re-enters markets.
“if that continues to hold that means that people are really saying there's a small amount of real inflation, a reasonable amount of transitory inflation. And we're about to kind of wash most of it through the system with a 100 basis points of rate hikes. And if that's the case, then you may see a quick pullback in Q1. And we're back to the races again because of all this other money. That's going to say I got to get back in.”
View on YouTube
Explanation
There was no quick Q1 2022 pullback-then-rebound; instead markets fell steadily through 2022 as the Fed hiked far more than 100bps, ultimately to over 4.5%, and stocks kept declining through October 2022.
Over the subsequent 3–5 years from early 2022, hundreds of privately held companies that raised capital at high unicorn-level valuations will be unable to achieve comparable valuations in the public markets if they attempt to IPO on the basis of their then-current financial projections.
“there are hundreds of companies that have raised billions of dollars at valuations that if they look in the public markets now, they are never actually going to achieve. If they were to go public in the next three, 4 or 5 years based on their projections.”
View on YouTube
Explanation
Numerous unicorns that raised at 2021 peak valuations were unable to achieve comparable public-market valuations in subsequent years (e.g. Instacart, Stripe markdowns, WeWork bankruptcy), consistent with this prediction.
Among roughly 900 unicorn startups existing as of early 2022, many exits over the following years will be "pushes" in which companies sell for around or below their last private valuation, returning capital to preferred investors but delivering little or no return on those late-stage rounds.
“I think you're going to see a lot of pushes. No, I'm agreeing with you. Yes. I'm going to give you the examples. Then there's also.”
View on YouTube
Explanation
Many late-stage unicorns from the 2021 vintage indeed exited via down-rounds, acquihires, or "push" acquisitions returning little beyond invested capital over 2022-2024.
A significant share of late-stage venture-backed companies valued at $1B+ as of early 2022 will exit at prices that merely return invested capital to their most recent investors, rather than generating the 3–4x returns those investors typically target.
“I think it's going to be a lot of these pushes where I don't know what is it in blackjack, David, when you're playing those three hands and you get a push like and it's like, okay, I'm going to live to fight another hand”
View on YouTube
Explanation
Consistent with the broader down-round/flat-exit trend among 2021-vintage unicorns through 2022-2024.
Due to the Federal Reserve’s tightening stance as of early January 2022, the probability of the U.S. economy entering a recession at some point during calendar year 2022 is substantially elevated compared to prior expectations.
“I think there's actually like a much greater risk now of the economy going into recession this year because of the Fed's overreaction this week.”
View on YouTube
Explanation
The Fed's 2022 tightening did raise recession risk and a mild NBER-defined recession was never officially declared for 2022 despite two negative GDP quarters, so the "substantially elevated risk" framing was directionally right but no recession materialized that year.
In the current and near-term market downturn being discussed (post-2021), the startup ecosystem will not experience a crash as severe as 2000 or 2008 in which roughly a third of startups disappear or a large number of high-profile VC-backed companies are wiped out (i.e., no "Sequoia graveyard"-type outcome).
“I don't think we're running into that again. So, you know, let's not create a sequoia graveyard”
View on YouTube
Explanation
The 2022-2023 downturn, while painful, did not produce a 2000/2008-scale wipeout of roughly a third of startups; failures rose but nothing near dot-com-bust proportions occurred.
By roughly two years after this January 2022 recording (i.e., by early 2024), about 80% of aggregate capital deployed into private markets will come from only three or four investment firms (e.g., Andreessen Horowitz, Tiger Global, SoftBank, etc.).
“if you look at the aggregate capital that's being deployed into private markets right now, in probably two years, 80% of it's going to come from three firms or four firms.”
View on YouTube
Explanation
Capital concentration among mega-funds (a16z, Tiger, SoftBank, Sequoia) did increase, but precise verification of an "80% from 3-4 firms" figure by 2024 is not available; direction was right but the specific magnitude is unverifiable.
Andreessen Horowitz is very likely to be the first major venture capital firm to go public via an IPO, ahead of its VC peers, following its scale-up to private-equity-like assets under management.
“it's very likely it's very likely that you'll see Andreessen be the first.”
View on YouTube
Explanation
Andreessen Horowitz had not IPO'd as of 2026; no major traditional VC firm has gone public in this period.